New York, NY -- (SBWIRE) -- 12/12/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Sigma Labs Inc (OTCMKTS:SGLB), U.S. Geothermal Inc (NYSEMKT:HTM), Geron Corporation (NASDAQ:GERN), Visa Inc (NYSE:V)
Sigma Labs Inc (OTCMKTS:SGLB) showed a volume of 14.15 million shares by the end of last trade whereas the average volume of the stock remained 7.01 million shares. The stock opened the session at $0.20 but then moved to $0.181. At that price, the stock showed a negative performance of -11.06%. Sigma Labs, Inc. has two wholly-owned subsidiaries, B6 Sigma, Inc. and Sumner & Lawrence Limited (dba Sumner Associates). B6 Sigma, Inc. (B6 Sigma) develops precision manufacturing solutions and advanced materials technologies,
Will SGLB Get Buyers Even After The Recent Rally? Find Out Here
U.S. Geothermal Inc (NYSEMKT:HTM) opened the session at $2.63 and closed the session at $0.276. The stock showed a positive performance of 2.63% in previous trading session. .S. Geothermal Inc. (HTM) is engaged in the renewable green energy business. The Company, through its subsidiary, U.S. Geothermal Inc. (Geo-Idaho) are engaged in the acquisition, development and utilization of geothermal resources in the Western Region of the United States. The Company has interests in three areas in the Western United States. The interests include the Raft River area located in south-eastern Idaho,
For How Long HTM will fight for Profitability? Read This Trend Analysis report
Geron Corporation (NASDAQ:GERN) opened the session at $5.17 and closed the session at $4.66. The stock showed a negative performance of -9.51% in previous trading session. The beta of the stock remained 1.24. Geron Corporation (Geron) is a clinical-stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Telomerase is an enzyme that enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication.
Why Should Investors Buy GERN After the Recent Fall? Just Go Here and Find Out
Visa Inc (NYSE:V) the stock advanced 3.12% and finished the session at $205.66. Traded with volume of 10.08 million shares in the prior session and the average volume of the stock remained 2.82 million shares. The beta of the stock remained 0.53. Visa Inc. (Visa) is a global payments technology company that connects consumers, businesses, banks and governments in more than 200 countries and territories to fast, secure and reliable electronic payments. The Company operates processing networks, VisaNet, offering fraud protection for consumers and assured payment for merchants. The Company operates an open-loop payments network,
Will Visa Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)